Based on our findings in heart, we hypothesize that abnormal activation of ERK1/2 is similarly involved in the pathogenesis of skeletal muscular dystrophy in the LmnaH222P/H222P mouse model of EDMD. This evidence concerns the gene MAPK3 and Emery-Dreifuss muscular dystrophy.